This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. The Medical Cannabis Advisory Board (MCAB) convened four times in FY24.
Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Increase public outreach with the industry, newcomers to cannabis, advocacy groups, and the general public.
There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.
The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.
The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”
The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.
The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.
Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.
MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Here’s what they found.
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Men were more likely than women to treat pain with cannabis.
A widely reported study appearing today in the British journal The Lancet alleges that an estimated 30 to 50 percent of psychosis cases in Europe are due to cannabis exposure, and that exposure to elevated levels of THC increases this risk. But it is not evidence that marijuana in any way causes the condition.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”
When it comes to buying a cannabis enthusiast’s home, the resale value research is less clear, though 30% of realtors say they have struggled to sell a house where cannabis was grown. Legal cannabis raises home value. There’s been a lot of chatter surrounding cannabis and the real estate market.
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. These opioid-sparing effects were most pronounced among participants who had prior experience with cannabis.
The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.
The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”
1 When we invited Cannigma readers to try Slumber’s Deep Zzzs gummies for sleep, we were particularly interested in digging into the data on sleep quality – not just total sleep time. 2 While the data collection effort did not include a control group, the prime findings were found to be statistically significant. hours to 6.79
In accordance with this, a new study found that states with legal cannabis markets have been less likely to experience incidences of EVALI, suggesting that properly regulated vape pens are not the problem. An Analysis of Nationwide EVALI Data. ” The study also discovered impacts from other variances in policies across states.
Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s not really available in the cannabis industry,” he explained on the Cannabis Enigma podcast. Produced by Elana Goldberg and Michael Schaeffer Omer-Man.
Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.
study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. The groundbreaking study conducted by New Frontier Data surveyed over 3,000 adult Americans to show people from all age groups and demographics in the U.S. A Fascinating insight into Cannabis user profiles can be found here.
Smith eventually recovered, but “started to go down a really dark path” with the prescription medications, so he turned to cannabis. Years later, when medical cannabis was legalized in Maryland , where he lives, Smith told The Cannigma how he suddenly had access to a whole world of weed he had never encountered with his old dealer.
His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). The ORR is a web-based research platform open to adults and adult caregivers of dependents who are, or are considering, the use of cannabis or hemp products for therapeutic purposes.
Some recent highlights and curiosities from the amazing world of cannabis science and therapeutics: CBD and autism. In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Cannabis and ADHD.
A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes.
Cannabis and Keto, Keto and cannabis. Health, fitness, and cannabis enthusiasts are all singing the praises of combining cannabis and the keto diet. However, when it comes to cannabis and the keto diet, many people claim they actually enhance each other’s health benefits. 6 Keto and Cannabis Edibles 6.1
Cannabis suppositories haven’t (yet) made it to the spotlight. The data was collected during an 8-week engagement in collaboration with MoreBetter , and the results all point in the same direction — less overall menstrual distress, better mood, and more manageable cramps. absorption), at least with rectal insertion.
Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. Related story Can CBD Help Your Condition? CBD for hypertension. Preclinical promise.
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.
The TGA recently released a new medical cannabis dashboard detailing a variety of information on both SAS-A and SAS-B approvals. They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients.
Cannabis use is increasing all around the world. These surveys explore the motivations and methods behind cannabis usage for both medical purposes and recreational enjoyment. In this piece, we aim to delve into the use of cannabis among Generation Z (those born between 1997 and 2012) for purposes of happiness, healing, and relief.
The ketogenic diet (or keto diet) and cannabis can both individually have profound effects on the human body, but do these two popular lifestyle choices share more in common than meets the eye? Can keto affect the way cannabis works? As per usual, more data is needed. What to know if you’re going to mix keto and cannabis.
Oils, creams, skin balms, gels and serums made from cannabis come in all shapes and sizes, and many of these products promise to improve your skin and make it healthier. But how does cannabis actually affect the skin? Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g
In fact, a new study published in the Yale Journal of Biology and Medicine found that cannabis flower may provide near-immediate relief of depression symptoms! Cannabis users reported feeling relaxed, peaceful, happy and optimistic, and when measured on a quantitative scale of 0 to 10, users reported an average of a 3.76-point
Our bodies have a built-in framework ready to accept the active molecules in cannabis, like THC. This could lead one to believe we might actually be “hardwired” to consume cannabis, but this is not actually the case. Moreover cannabis has been used medicinally and recreationally for thousands of years.
Medical cannabis use and identity: The role of state laws By Dr. Amanda Reiman (Ph.D., MSW), Chief Knowledge Officer, New Frontier Data One of the defining characteristics of state medical cannabis programs is the list of qualifying conditions.
Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. This data aligns with Americans’ rising acceptance of cannabis. The most popular qualifying conditions continue to be chronic pain and PTSD, some of which may be related to the pandemic.
From making music and movies better to easing pain and inflammation, the health and wellness benefits of cannabis are truly impressive. But what exactly are cannabis topicals, and more importantly, do they actually work? What are cannabis topicals? Do cannabis topicals work — and can they get you high?
Back in 2018, San Francisco voters approved a 1-5% cannabis business tax slated to go into effect early 2022. After three hard years for the city’s cannabis industry however, plans to implement the tax have gone out the window. Recent data from the California Legislative Analyst Office backs Mandelman’s claim.
Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition.
As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Why Do MMJ Patients Use Cannabis? Many patients take MMJ for more reasons than one.
Kathy Hochul signed a bill today, clearing the way for qualified farmers to begin planting cannabis this spring. 8084-a , establishing conditional use cultivator licenses to cannabis cultivators who will then be able to process and distribute products. S8084A (ACTIVE) – SUMMARY. Michelle Hinchey’s bill S.8084-a
Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. Gordon has been featured in the Netflix documentary, Weed the People , and owns and operates two medical cannabis companies. Why cannabis?
On July 1st, 2021, new cannabis legalization are going into effect in Connecticut, New Mexico, and Virginia, just a couple days after a recreational cannabis legalization measure went into effect in South Dakota. Nearly half of all Americans now live in states where cannabis is legal for adult use. In Colorado, 78.7%
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content